Insider Buying: 10x Genomics (NYSE:TXG) Major Shareholder Purchases 187,500 Shares of Stock

Share on StockTwits

10x Genomics (NYSE:TXG) major shareholder Foresite Capital Fund I, L.P. bought 187,500 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average cost of $39.00 per share, for a total transaction of $7,312,500.00. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

About 10x Genomics

10x Genomics, Inc, a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems.

Recommended Story: What economic reports are most valuable to investors?

Receive News & Ratings for 10x Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 10x Genomics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

ELEKTA AB/ADR  Raised to “Buy” at Zacks Investment Research
ELEKTA AB/ADR Raised to “Buy” at Zacks Investment Research
Iridium  Trading Down 4.6% Over Last Week
Iridium Trading Down 4.6% Over Last Week
Monero Tops 24-Hour Trading Volume of $87.24 Million
Monero Tops 24-Hour Trading Volume of $87.24 Million
Dash  Trading Down 7.7% Over Last Week
Dash Trading Down 7.7% Over Last Week
BigUp  Reaches 24 Hour Trading Volume of $22.00
BigUp Reaches 24 Hour Trading Volume of $22.00
SmartMesh  Trading 4.6% Lower  Over Last Week
SmartMesh Trading 4.6% Lower Over Last Week


© 2006-2019 Ticker Report